ICLUSIG (ponatinib) tablets. FDA-Approved

ICLUSIG (ponatinib) tablets can be ordered by patient or doctor, if the drug has not been approved or is not available in your country. Medvitaz Pharma Solutions can help you from India to get best price/cost of ICLUSIG (ponatinib) tablets to treat chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL.
Categories: , .

ICLUSIG (ponatinib) tablets. FDA-Approved

What is FDA-approved ICLUSIG (ponatinib) tablets indicated for?

ICLUSIG (ponatinib) tablets is a prescription medicine. ICLUSIG (ponatinib) tablets is used to treat chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL.
INDICATIONS AND USAGE
Iclusig is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
DOSAGE FORMS & STRENGTHS
Tablets: 15 mg and 45 mg
Manufactured By: ARIAD Pharmaceuticals, Inc.
Prescribing Information URL: Click Here

How to make an enquiry for ICLUSIG (ponatinib) tablets?

Anticancer medicine ICLUSIG (ponatinib) tablets available upon request. To get best price in india, Call 9811747774 or Email info@medvitaz.com to discuss advanced treatments with Breast Cancer Specialists in India without travel. Medvitaz Pharma Solutions can help you to get genuine, affordable and assurance of delivery of approved medicines for Blood Cancer.

What ponatinib is indicated for?

Ponatinib (trade name Iclusig /aɪˈkluːsɪɡ/ eye-KLOO-sig, previously AP24534) is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors.

Ponatinib was approved by the US FDA on December 14, 2012, for patients with resistant or intolerant CML and Ph+ ALL, based on results of the PACE phase II trial reported days earlier at the annual ASH meeting. Because the approval was under the FDA Accelerated Approval program the applicant was required to carry out additional studies. Based on these additional studies, the FDA granted in 2016 full approval and updated the label to include patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia for whom no other tyrosine kinase inhibitor therapy is indicated. Approval was also granted for T315I-positive and T315I-positive Philadelphia chromosome positive acute lymphoblastic leukemia.

How and where to buy ICLUSIG (ponatinib) tablets?

You can order ICLUSIG (ponatinib) tablets from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery of approved medicines for Blood Cancer. To get best price/cost of ICLUSIG (ponatinib) tablets in India, Call 8750295029 or Email urgent@medvitaz.com

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.